Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
CALL
NetApp
NTAP
$39B
| $2.62M | ﹤0.01% |
59,000
-33,800
| -36% | -$1.45M |
|
1852
Iridium Communications
IRDM
$5.23B
| $2.62M | ﹤0.01% |
102,871
-48,589
| -32% | -$1.14M |
|
1853
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $2.61M | ﹤0.01% |
+67,366
| New | +$2.46M |
|
1854
Fiverr
FVRR
$327M
| $2.61M | ﹤0.01% |
35,400
+31,400
| +785% | +$1.61M |
|
1855
iShares MSCI South Africa ETF
EZA
$579M
| $2.61M | ﹤0.01% |
74,001
+74,000
| +7,400,000% | +$2.44M |
|
1856
PUT
Rio Tinto
RIO
$166B
| $2.61M | ﹤0.01% |
46,400
+18,000
| +63% | +$912K |
|
1857
MacroGenics
MGNX
$259M
| $2.6M | ﹤0.01% |
93,254
+76,230
| +448% | +$1.32M |
|
|
HPP
1858
Hudson Pacific Properties
HPP
$740M
| $2.59M | ﹤0.01% |
14,729
-3,712
| -20% | -$632K |
|
1859
AtriCure
ATRC
$2.12B
| $2.59M | ﹤0.01% |
57,648
-163,731
| -74% | -$7.13M |
|
1860
Hanover Insurance
THG
$7.86B
| $2.59M | ﹤0.01% |
25,549
+5,284
| +26% | +$518K |
|
1861
White Mountains Insurance
WTM
$5.04B
| $2.58M | ﹤0.01% |
2,911
-4,425
| -60% | -$3.99M |
|
|
WUBA
1862
DELISTED
58.com Inc
WUBA
| $2.58M | ﹤0.01% |
47,871
-8,962
| -16% | -$462K |
|
1863
CALL
Ionis Pharmaceuticals
IONS
$9.46B
| $2.58M | ﹤0.01% |
43,800
-9,000
| -17% | -$501K |
|
|
CLVS
1864
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.57M | ﹤0.01% |
381,106
+287,894
| +309% | +$2.18M |
|
1865
PUT
CME Group
CME
$94.8B
| $2.57M | ﹤0.01% |
15,800
-34,300
| -68% | -$6.15M |
|
1866
First Interstate BancSystem
FIBK
$3.56B
| $2.56M | ﹤0.01% |
82,648
+16,012
| +24% | +$489K |
|
1867
Avista
AVA
$3.2B
| $2.56M | ﹤0.01% |
70,264
+15,066
| +27% | +$597K |
|
|
JWN
1868
CALL
DELISTED
Nordstrom
JWN
| $2.56M | ﹤0.01% |
165,100
-137,800
| -45% | -$2.43M |
|
|
DCPH
1869
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.56M | ﹤0.01% |
42,800
-15,120
| -26% | -$809K |
|
1870
Applied Industrial Technologies
AIT
$13.2B
| $2.55M | ﹤0.01% |
40,931
-974
| -2% | -$53.1K |
|
|
NSA
1871
DELISTED
National Storage Affiliates Trust
NSA
| $2.55M | ﹤0.01% |
89,098
-28,302
| -24% | -$811K |
|
1872
Northwest Natural Holdings
NWN
$2.09B
| $2.55M | ﹤0.01% |
45,715
-5,934
| -11% | -$362K |
|
1873
Matador Resources
MTDR
$6.49B
| $2.55M | ﹤0.01% |
299,882
+254,338
| +558% | +$1.78M |
|
1874
Strategic Education
STRA
$1.84B
| $2.55M | ﹤0.01% |
16,597
-8,685
| -34% | -$1.35M |
|
1875
iShares MSCI Chile ETF
ECH
$1.05B
| $2.54M | ﹤0.01% |
100,989
-48,645
| -33% | -$1.21M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.